(131)I-Caerin 1.1 and (131)I-Caerin 1.9 for the treatment of non-small-cell lung cancer

OBJECTIVE: To investigate the effect of the (131)I-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC cells. METHODS: ① 3-[4,5-Dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and plate clone formation assays were performed to confirm the in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Na, He, Tiantian, Xiao, Zewei, Du, Juan, Zhu, Keke, Liu, Xiongying, Chen, Tongsheng, Liu, Wenjuan, Ni, Guoying, Liu, Xiaosong, Wang, Tianfang, Quan, Jiangtao, Zhang, Jinhe, Zhang, Peipei, Yuan, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420947/
https://www.ncbi.nlm.nih.gov/pubmed/36046040
http://dx.doi.org/10.3389/fonc.2022.861206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420947/
https://www.ncbi.nlm.nih.gov/pubmed/36046040
http://dx.doi.org/10.3389/fonc.2022.861206

Ejemplares similares